γ-Aminobutyric acid |
カタログ番号GC38010 |
γ-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the adult brain.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 56-12-2
Sample solution is provided at 25 µL, 10mM.
γ-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the adult brain. Published values for γ-Aminobutyric acid EC50 range from 6.6μM – 107μM [1]. γ-Aminobutyric acid plays a role in fast inhibitory synaptic transmission mainly through cytosolic-mediated presynaptic γ-Aminobutyric acid release and postsynaptic activation of low-affinity GABAA receptors (GABAAR) [2]. γ-Aminobutyric acid plays an important role not only in the brain but also in different metabolic organs [3]. Therefore, γ-Aminobutyric acid is commonly used in studies such as multiple neurologic and metabolic diseases.
In vitro, γ-Aminobutyric acid (100μM) effectively reduced glutathione (GSH) depletion and the activities of antioxidant enzymes such as catalase (CAT) and superoxide dismutase (SOD) in C2C12 myoblasts [4]. γ-Aminobutyric acid at 10mM or lower concentrations showed no significant toxicity in MC3T3-E1 cells, and 20mM or higher concentrations resulted in significant cell death [5]. γ-Aminobutyric acid (100μM and 200μM) effectively reversed the inhibitory effect of H2O2 (100μM) on the proliferation of HUVECs [6].
In vivo, γ-Aminobutyric acid was administered orally by force-feeding to Sprague-Dawley rats for 13 weeks at doses of 500, 1250, and 2500mg/kg/day, and there were no toxicologically significant changes in clinical signs, hematology, clinical chemistry, and histopathological changes in rats, indicating that the rats tolerated γ-Aminobutyric acid at doses up to 2500mg/kg/day [7]. γ-Aminobutyric acid (500μmol [50mg]) was intraperitoneally injected into C57BL/6NHsd mice for 7 days, followed by 500μg of tumor necrosis factor-α (TNF-α) and 20mg of D-galactosamine intraperitoneally to induce acute hepatic failure in the mice, which was induced 4-5h after the injection using Western blot and immunohistochemistry and histopathology to analyze the proteins present in the blood samples and liver tissues of the mice showed that γ-Aminobutyric acid can inhibit apoptosis through the STAT3 signaling pathway [8].
References:
[1] Zhu, S.e.a.S.o.a.h.s.G.r.N.v., 7712 (2018): 67-72. doi:10.1038/s41586-018-0255-3.
[2] Koh W, K.H., Cheong E, Lee CJ, GABA tone regulation and its cognitive functions in the brain. Nat Rev Neurosci, 2023 Sep;24(9):523-539.
[3] Kim, K., and Haejin Yoon, Gamma-Aminobutyric Acid Signaling in Damage Response, Metabolism, and Disease. International journal of molecular sciences, vol. 24,5 4584. 26 Feb. 2023.
[4] Choe H, L.H., Lee J, Kim Y. Protective effect of gamma-aminobutyric acid against oxidative stress by inducing phase II enzymes in C2C12 myoblast cells. J Food Biochem. 2021 Apr;45(4):e13639. doi: 10.1111/jfbc.13639. Epub 2021 Feb 3. PMID: 33533516.
[5] Arachchilage Hasitha Maduranga Karunarathne W, H.C.Y., Lee MH, Kang CH, Kim GY. Gamma-aminobutyric acid (GABA)-mediated bone formation and its implications for anti-osteoporosis strategies: Exploring the relation between GABA and GABA receptors. Biochem Pharmacol. 2023 Dec;218:115888. doi: 10.1016/j.bcp.2023.115888. Epub 2023 Oct 29. PMID: 38084676.
[6] Zhu Z, S.Z., Xie C, Gong W, Hu Z, Peng Y. A novel mechanism of Gamma-aminobutyric acid (GABA) protecting human umbilical vein endothelial cells (HUVECs) against H2O2-induced oxidative injury. Comp Biochem Physiol C Toxicol Pharmacol. 2019 Mar;217:68-75. doi: 10.1016/j.cbpc.2018.11.018. Epub 2018 Nov 27. PMID: 30500452.
[7] Takeshima K, Y.A., Yamashita Y, Watabe K, Horie N, et al. Subchronic toxicity evaluation of gamma-aminobutyric acid (GABA) in rats. Food Chem Toxicol 2014:68:128–134.
[8] Hata, T.e.a.G., γ-Aminobutyric Acid, Protects Against Severe Liver Injury.” The Journal of surgical research vol. 236 (2019): 172-183. doi:10.1016/j.jss.2018.11.047.
Cell experiment [1]: | |
Cell lines | C2C12 myoblasts |
Preparation Method | C2C12 cells were treated with various concentration of γ-Aminobutyric acid (25, 50, and 100μM) for 24h, and then, exposed to 600μM of H2O2 for 2h. Finally, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to measure the cytotoxicity. |
Reaction Conditions | 25, 50 and 100μM; 24h |
Applications | H2O2 (600μM) decreased the cell viability of C2C12 myoblasts. However, γ-Aminobutyric acid treatment significantly increased the cell viability in a concentration-dependent manner. Remarkably, treatment with 100μM of γ-Aminobutyric acid showed the highest cytoprotection against oxidative stress in C2C12 myoblasts. |
Animal experiment [2]: | |
Animal models | Sprague-Dawley rats |
Preparation Method | Treated the Sprague-Dawley rats by intraperitoneal injection of γ-Aminobutyric acid (1.5mg/kg) or the GAD inhibitor l-allylglycine (40mg/kg) for 3 days, and then analysis the expression of γ-Aminobutyric acid-ergic signaling proteins in the rat liver. |
Dosage form | 1.5mg/kg/day for 3 days; i.p. injection |
Applications | γ-Aminobutyric acid (1.5mg/kg) did not affect the levels of total bilirubin, ALT, and AST in Sprague-Dawley rats. However, inhibition of endogenous γ-Aminobutyric acid production by l-allylglycine (a kind of γ-Aminobutyric acid synthetase inhibitor) significantly decreased blood glucose level. |
References: |
Cas No. | 56-12-2 | SDF | |
Canonical SMILES | O=C(O)CCCN | ||
Formula | C4H9NO2 | M.Wt | 103.12 |
溶解度 | Water: ≥ 50 mg/mL (484.87 mM) | Storage | Store at RT |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Prepare stock solution | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 9.6974 mL | 48.4872 mL | 96.9744 mL |
5 mM | 1.9395 mL | 9.6974 mL | 19.3949 mL |
10 mM | 0.9697 mL | 4.8487 mL | 9.6974 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5
(Based on Reviews and 38 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *